The MGBlab Gut-Brain Laboratory, as the core research platform of Zhongke Weizhi, is driven by the "microecology × AI" technology. Relying on the world's largest Chinese breast milk strain library (MMB), it has discovered clinical-level star strains such as BL-11 and LR99. Through the three innovative platforms of global leading strain research (IMM), AI collaborative formula (CFP), and microecological big model (SMART), it achieves a full-chain innovation of "breast milk strain screening → AI precise matching → disease prediction and intervention".

Based on the "菌脉传承" theory， we are committed to continuing the initial health protection power of life. With the goal of "becoming a Bell Laboratory in the field of probiotics" and the mission of "becoming the innovation engine of microecological health"， we uphold the values of respecting science， equality of life， and open symbiosis， and reshape a new health paradigm from disease treatment to microecological prevention.